Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of the Changes in the Signalling Pathways During Spinal Cord Injury-induced Skeletal Muscle Atrophy

NCT01470950 is registered in ClinicalTrials.gov with Clinique Romande de Readaptation as lead sponsor.

NCT NCT01470950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01470950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of the Changes in the Signalling Pathways During Spinal Cord Injury-induced Skeletal Muscle Atrophy
Lead sponsor
Clinique Romande de Readaptation
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2010
Completion date
December 31, 2015
Enrollment
28 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

muscle atrophy, spinal cord injuries